DENVER--(BUSINESS WIRE)--Dec. 20, 2005--Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a development stage biopharmaceutical company, (OTCBB: CGXP) today announced that it...
DENVER--(BUSINESS WIRE)--Dec. 6, 2005--Ceragenix Pharmaceuticals, Inc., ("Ceragenix" or the "Company"), a development stage biopharmaceutical company, (OTCBB:CGXP) today announced that it had...
#8: CGXP News Ceragenix Signs Letter of Intent with the Centers for Disease Control and Prevention (CDC) to Enter into a Cooperative Research and Development Agreement (CRADA)
DENVER--(BUSINESS WIRE)--Oct. 25, 2005-- The CRADA Will Evaluate the Efficacy of Ceragenix's Cationic Steroid Antibiotic ("CSA") Antimicrobial Coating in the Prevention of Bacterial Biofilm...
DENVER--(BUSINESS WIRE)--Sept. 26, 2005--Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company") (OTCBB: CGXP), a development stage biopharmaceutical company, today announced that Ceragenix...
#6: CGXP News Ceragenix Reports Results of Study of Its Epiceram (TM) Barrier Repair Cream; Study Demonstrates That Epiceram(TM) Accelerated Skin Barrier Recovery in Treated vs. Untreated Eczema Sites
DENVER--(BUSINESS WIRE)--Sept. 15, 2005--Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company) (OTCBB: CGXP), a development-stage biopharmaceutical company, today announced that the results...
#5: CGXP News Webcast Alert: Ceragenix Pharmaceuticals, Inc. Presentation at Informed Investors Biotechnology, Healthcare, Pharmaceuticals Investor Forum to be Webcast on Thursday, August 25, 2005, 12:30 pm ET
DENVER--(BUSINESS WIRE)--Aug. 24, 2005--Ceragenix Pharmaceuticals, Inc. (OTCBB: CGXP) will present at the following forum: What: Ceragenix Pharmaceuticals, Inc. (OTCBB: CGXP) will give a...
DENVER--(BUSINESS WIRE)--Aug. 17, 2005-- NIH Funded Study to Evaluate Ceragenix's Barrier Repair Technology as Potential Method to Prevent Potentially Fatal Complication of Smallpox...
DENVER--(BUSINESS WIRE)--Aug. 3, 2005--Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company") (OTCBB:CGXP) today announced that Professor Richard Gallo has joined the Company's Scientific...
Professor Sean P. Gorman Joins Ceragenix Pharmaceuticals' Scientific Advisory Board; World Renowned Expert in Medical Device Coatings
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company")...
Ceragenix's Lead Compounds Show Anti-Angiogenic Activity; National Cancer Institute Accepts Compounds for Testing
Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP) today announced that...
